img

Global Sleeping Pills Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sleeping Pills Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Sleeping Pills market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Sleeping Pills is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Sleeping Pills is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Sleeping Pills is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Sleeping Pills include Sanofi, Abbott Laboratories, Takeda Pharmaceutical, Apotex, Aurobindo Pharma, Actellon Pharmaceuticals, Allegiant Health, Cayman Chemical and Ambitropin, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Sleeping Pills, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Sleeping Pills by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Sleeping Pills market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Sleeping Pills market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
By Type
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
By Application
Hospital Pharmacy
Retail Pharmacy
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Sleeping Pills in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Sleeping Pills manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sleeping Pills sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Sleeping Pills Definition
1.2 Market by Type
1.2.1 Global Sleeping Pills Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Zolpidem
1.2.3 Eszopiclone (Lunesta)
1.2.4 Ramelteon (Rozerem)
1.2.5 Ativan (lorazepam)
1.2.6 Adapin (doxepin)
1.3 Market Segment by Application
1.3.1 Global Sleeping Pills Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Sleeping Pills Sales
2.1 Global Sleeping Pills Revenue Estimates and Forecasts 2018-2034
2.2 Global Sleeping Pills Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Sleeping Pills Revenue by Region
2.3.1 Global Sleeping Pills Revenue by Region (2018-2023)
2.3.2 Global Sleeping Pills Revenue by Region (2024-2034)
2.4 Global Sleeping Pills Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Sleeping Pills Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Sleeping Pills Sales Quantity by Region
2.6.1 Global Sleeping Pills Sales Quantity by Region (2018-2023)
2.6.2 Global Sleeping Pills Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Sleeping Pills Sales Quantity by Manufacturers
3.1.1 Global Sleeping Pills Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Sleeping Pills Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Sleeping Pills Sales in 2024
3.2 Global Sleeping Pills Revenue by Manufacturers
3.2.1 Global Sleeping Pills Revenue by Manufacturers (2018-2023)
3.2.2 Global Sleeping Pills Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Sleeping Pills Revenue in 2024
3.3 Global Sleeping Pills Sales Price by Manufacturers
3.4 Global Key Players of Sleeping Pills, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sleeping Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sleeping Pills, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sleeping Pills, Product Offered and Application
3.8 Global Key Manufacturers of Sleeping Pills, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Sleeping Pills Sales Quantity by Type
4.1.1 Global Sleeping Pills Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Sleeping Pills Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
4.2 Global Sleeping Pills Revenue by Type
4.2.1 Global Sleeping Pills Historical Revenue by Type (2018-2023)
4.2.2 Global Sleeping Pills Forecasted Revenue by Type (2024-2034)
4.2.3 Global Sleeping Pills Revenue Market Share by Type (2018-2034)
4.3 Global Sleeping Pills Price by Type
4.3.1 Global Sleeping Pills Price by Type (2018-2023)
4.3.2 Global Sleeping Pills Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Sleeping Pills Sales Quantity by Application
5.1.1 Global Sleeping Pills Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Sleeping Pills Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
5.2 Global Sleeping Pills Revenue by Application
5.2.1 Global Sleeping Pills Historical Revenue by Application (2018-2023)
5.2.2 Global Sleeping Pills Forecasted Revenue by Application (2024-2034)
5.2.3 Global Sleeping Pills Revenue Market Share by Application (2018-2034)
5.3 Global Sleeping Pills Price by Application
5.3.1 Global Sleeping Pills Price by Application (2018-2023)
5.3.2 Global Sleeping Pills Price Forecast by Application (2024-2034)
6 North America
6.1 North America Sleeping Pills Sales by Company
6.1.1 North America Sleeping Pills Revenue by Company (2018-2023)
6.1.2 North America Sleeping Pills Sales Quantity by Company (2018-2023)
6.2 North America Sleeping Pills Market Size by Type
6.2.1 North America Sleeping Pills Sales Quantity by Type (2018-2034)
6.2.2 North America Sleeping Pills Revenue by Type (2018-2034)
6.3 North America Sleeping Pills Market Size by Application
6.3.1 North America Sleeping Pills Sales Quantity by Application (2018-2034)
6.3.2 North America Sleeping Pills Revenue by Application (2018-2034)
6.4 North America Sleeping Pills Market Size by Country
6.4.1 North America Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Sleeping Pills Revenue by Country (2018-2034)
6.4.3 North America Sleeping Pills Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sleeping Pills Sales by Company
7.1.1 Europe Sleeping Pills Sales Quantity by Company (2018-2023)
7.1.2 Europe Sleeping Pills Revenue by Company (2018-2023)
7.2 Europe Sleeping Pills Market Size by Type
7.2.1 Europe Sleeping Pills Sales Quantity by Type (2018-2034)
7.2.2 Europe Sleeping Pills Revenue by Type (2018-2034)
7.3 Europe Sleeping Pills Market Size by Application
7.3.1 Europe Sleeping Pills Sales Quantity by Application (2018-2034)
7.3.2 Europe Sleeping Pills Revenue by Application (2018-2034)
7.4 Europe Sleeping Pills Market Size by Country
7.4.1 Europe Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Sleeping Pills Revenue by Country (2018-2034)
7.4.3 Europe Sleeping Pills Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Sleeping Pills Sales by Company
8.1.1 China Sleeping Pills Sales Quantity by Company (2018-2023)
8.1.2 China Sleeping Pills Revenue by Company (2018-2023)
8.2 China Sleeping Pills Market Size by Type
8.2.1 China Sleeping Pills Sales Quantity by Type (2018-2034)
8.2.2 China Sleeping Pills Revenue by Type (2018-2034)
8.3 China Sleeping Pills Market Size by Application
8.3.1 China Sleeping Pills Sales Quantity by Application (2018-2034)
8.3.2 China Sleeping Pills Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Sleeping Pills Sales by Company
9.1.1 APAC Sleeping Pills Sales Quantity by Company (2018-2023)
9.1.2 APAC Sleeping Pills Revenue by Company (2018-2023)
9.2 APAC Sleeping Pills Market Size by Type
9.2.1 APAC Sleeping Pills Sales Quantity by Type (2018-2034)
9.2.2 APAC Sleeping Pills Revenue by Type (2018-2034)
9.3 APAC Sleeping Pills Market Size by Application
9.3.1 APAC Sleeping Pills Sales Quantity by Application (2018-2034)
9.3.2 APAC Sleeping Pills Revenue by Application (2018-2034)
9.4 APAC Sleeping Pills Market Size by Region
9.4.1 APAC Sleeping Pills Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Sleeping Pills Revenue by Region (2018-2034)
9.4.3 APAC Sleeping Pills Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sleeping Pills Sales by Company
10.1.1 Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Sleeping Pills Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Sleeping Pills Market Size by Type
10.2.1 Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Sleeping Pills Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Sleeping Pills Market Size by Application
10.3.1 Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Sleeping Pills Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Sleeping Pills Market Size by Country
10.4.1 Middle East, Africa and Latin America Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Sleeping Pills Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Sanofi Sleeping Pills Products and Services
11.1.5 Sanofi Sleeping Pills SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Abbott Laboratories Sleeping Pills Products and Services
11.2.5 Abbott Laboratories Sleeping Pills SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Information
11.3.2 Takeda Pharmaceutical Overview
11.3.3 Takeda Pharmaceutical Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Takeda Pharmaceutical Sleeping Pills Products and Services
11.3.5 Takeda Pharmaceutical Sleeping Pills SWOT Analysis
11.3.6 Takeda Pharmaceutical Recent Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Overview
11.4.3 Apotex Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Apotex Sleeping Pills Products and Services
11.4.5 Apotex Sleeping Pills SWOT Analysis
11.4.6 Apotex Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Aurobindo Pharma Sleeping Pills Products and Services
11.5.5 Aurobindo Pharma Sleeping Pills SWOT Analysis
11.5.6 Aurobindo Pharma Recent Developments
11.6 Actellon Pharmaceuticals
11.6.1 Actellon Pharmaceuticals Company Information
11.6.2 Actellon Pharmaceuticals Overview
11.6.3 Actellon Pharmaceuticals Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Actellon Pharmaceuticals Sleeping Pills Products and Services
11.6.5 Actellon Pharmaceuticals Sleeping Pills SWOT Analysis
11.6.6 Actellon Pharmaceuticals Recent Developments
11.7 Allegiant Health
11.7.1 Allegiant Health Company Information
11.7.2 Allegiant Health Overview
11.7.3 Allegiant Health Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Allegiant Health Sleeping Pills Products and Services
11.7.5 Allegiant Health Sleeping Pills SWOT Analysis
11.7.6 Allegiant Health Recent Developments
11.8 Cayman Chemical
11.8.1 Cayman Chemical Company Information
11.8.2 Cayman Chemical Overview
11.8.3 Cayman Chemical Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Cayman Chemical Sleeping Pills Products and Services
11.8.5 Cayman Chemical Sleeping Pills SWOT Analysis
11.8.6 Cayman Chemical Recent Developments
11.9 Ambitropin
11.9.1 Ambitropin Company Information
11.9.2 Ambitropin Overview
11.9.3 Ambitropin Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Ambitropin Sleeping Pills Products and Services
11.9.5 Ambitropin Sleeping Pills SWOT Analysis
11.9.6 Ambitropin Recent Developments
11.10 Hayao
11.10.1 Hayao Company Information
11.10.2 Hayao Overview
11.10.3 Hayao Sleeping Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Hayao Sleeping Pills Products and Services
11.10.5 Hayao Sleeping Pills SWOT Analysis
11.10.6 Hayao Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Sleeping Pills Value Chain Analysis
12.2 Sleeping Pills Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sleeping Pills Production Mode & Process
12.4 Sleeping Pills Sales and Marketing
12.4.1 Sleeping Pills Sales Channels
12.4.2 Sleeping Pills Distributors
12.5 Sleeping Pills Customers
13 Market Dynamics
13.1 Sleeping Pills Industry Trends
13.2 Sleeping Pills Market Drivers
13.3 Sleeping Pills Market Challenges
13.4 Sleeping Pills Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sleeping Pills Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Zolpidem
Table 3. Major Manufacturers of Eszopiclone (Lunesta)
Table 4. Major Manufacturers of Ramelteon (Rozerem)
Table 5. Major Manufacturers of Ativan (lorazepam)
Table 6. Major Manufacturers of Adapin (doxepin)
Table 7. Global Sleeping Pills Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Sleeping Pills Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Sleeping Pills Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Sleeping Pills Revenue Market Share by Region (2018-2023)
Table 11. Global Sleeping Pills Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Sleeping Pills Revenue Market Share by Region (2024-2034)
Table 13. Global Sleeping Pills Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Sleeping Pills Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Sleeping Pills Sales Market Share by Region (2018-2023)
Table 16. Global Sleeping Pills Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Sleeping Pills Sales Market Share by Region (2024-2034)
Table 18. Global Sleeping Pills Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Sleeping Pills Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Sleeping Pills Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Sleeping Pills Revenue Share by Manufacturers (2018-2023)
Table 22. Global Sleeping Pills Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Sleeping Pills, Industry Ranking, 2021 VS 2024
Table 24. Global Sleeping Pills Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Sleeping Pills by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sleeping Pills as of 2024)
Table 26. Global Key Manufacturers of Sleeping Pills, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Sleeping Pills, Product Offered and Application
Table 28. Global Key Manufacturers of Sleeping Pills, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Sleeping Pills Sales Quantity Share by Type (2018-2023)
Table 33. Global Sleeping Pills Sales Quantity Share by Type (2024-2034)
Table 34. Global Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Sleeping Pills Revenue Share by Type (2018-2023)
Table 37. Global Sleeping Pills Revenue Share by Type (2024-2034)
Table 38. Sleeping Pills Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Sleeping Pills Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Sleeping Pills Sales Quantity Share by Application (2018-2023)
Table 43. Global Sleeping Pills Sales Quantity Share by Application (2024-2034)
Table 44. Global Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Sleeping Pills Revenue Share by Application (2018-2023)
Table 47. Global Sleeping Pills Revenue Share by Application (2024-2034)
Table 48. Sleeping Pills Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Sleeping Pills Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Sleeping Pills Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Sleeping Pills Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Sleeping Pills Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Sleeping Pills Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Sleeping Pills Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Sleeping Pills Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Sleeping Pills Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Sleeping Pills Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Sleeping Pills Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Sleeping Pills Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Sleeping Pills Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Sleeping Pills Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Sleeping Pills Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Sleeping Pills Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Sleeping Pills Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Sleeping Pills Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Sleeping Pills Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Sleeping Pills Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Sleeping Pills Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Sleeping Pills Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Sleeping Pills Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Sleeping Pills Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Sleeping Pills Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Sleeping Pills Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Sleeping Pills Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Sleeping Pills Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Sleeping Pills Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Sleeping Pills Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Sleeping Pills Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Sleeping Pills Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Overview
Table 122. Sanofi Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Sanofi Sleeping Pills Product and Services
Table 124. Sanofi Sleeping Pills SWOT Analysis
Table 125. Sanofi Recent Developments
Table 126. Abbott Laboratories Company Information
Table 127. Abbott Laboratories Description and Overview
Table 128. Abbott Laboratories Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Abbott Laboratories Sleeping Pills Product and Services
Table 130. Abbott Laboratories Sleeping Pills SWOT Analysis
Table 131. Abbott Laboratories Recent Developments
Table 132. Takeda Pharmaceutical Company Information
Table 133. Takeda Pharmaceutical Description and Overview
Table 134. Takeda Pharmaceutical Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Takeda Pharmaceutical Sleeping Pills Product and Services
Table 136. Takeda Pharmaceutical Sleeping Pills SWOT Analysis
Table 137. Takeda Pharmaceutical Recent Developments
Table 138. Apotex Company Information
Table 139. Apotex Description and Overview
Table 140. Apotex Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Apotex Sleeping Pills Product and Services
Table 142. Apotex Sleeping Pills SWOT Analysis
Table 143. Apotex Recent Developments
Table 144. Aurobindo Pharma Company Information
Table 145. Aurobindo Pharma Description and Overview
Table 146. Aurobindo Pharma Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Aurobindo Pharma Sleeping Pills Product and Services
Table 148. Aurobindo Pharma Sleeping Pills SWOT Analysis
Table 149. Aurobindo Pharma Recent Developments
Table 150. Actellon Pharmaceuticals Company Information
Table 151. Actellon Pharmaceuticals Description and Overview
Table 152. Actellon Pharmaceuticals Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Actellon Pharmaceuticals Sleeping Pills Product and Services
Table 154. Actellon Pharmaceuticals Sleeping Pills SWOT Analysis
Table 155. Actellon Pharmaceuticals Recent Developments
Table 156. Allegiant Health Company Information
Table 157. Allegiant Health Description and Overview
Table 158. Allegiant Health Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. Allegiant Health Sleeping Pills Product and Services
Table 160. Allegiant Health Sleeping Pills SWOT Analysis
Table 161. Allegiant Health Recent Developments
Table 162. Cayman Chemical Company Information
Table 163. Cayman Chemical Description and Overview
Table 164. Cayman Chemical Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Cayman Chemical Sleeping Pills Product and Services
Table 166. Cayman Chemical Sleeping Pills SWOT Analysis
Table 167. Cayman Chemical Recent Developments
Table 168. Ambitropin Company Information
Table 169. Ambitropin Description and Overview
Table 170. Ambitropin Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 171. Ambitropin Sleeping Pills Product and Services
Table 172. Ambitropin Sleeping Pills SWOT Analysis
Table 173. Ambitropin Recent Developments
Table 174. Hayao Company Information
Table 175. Hayao Description and Overview
Table 176. Hayao Sleeping Pills Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 177. Hayao Sleeping Pills Product and Services
Table 178. Hayao Sleeping Pills SWOT Analysis
Table 179. Hayao Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Sleeping Pills Distributors List
Table 183. Sleeping Pills Customers List
Table 184. Sleeping Pills Market Trends
Table 185. Sleeping Pills Market Drivers
Table 186. Sleeping Pills Market Challenges
Table 187. Sleeping Pills Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Sleeping Pills Product Picture
Figure 2. Global Sleeping Pills Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Sleeping Pills Market Share by Type in 2024 & 2034
Figure 4. Zolpidem Product Picture
Figure 5. Eszopiclone (Lunesta) Product Picture
Figure 6. Ramelteon (Rozerem) Product Picture
Figure 7. Ativan (lorazepam) Product Picture
Figure 8. Adapin (doxepin) Product Picture
Figure 9. Global Sleeping Pills Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Sleeping Pills Market Share by Application in 2024 & 2034
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Sleeping Pills Report Years Considered
Figure 14. Global Sleeping Pills Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Sleeping Pills Revenue 2018-2034 (US$ Million)
Figure 16. Global Sleeping Pills Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Sleeping Pills Sales Quantity 2018-2034 (K Pcs)
Figure 18. Global Sleeping Pills Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Sleeping Pills Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Sleeping Pills Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 21. North America Sleeping Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Sleeping Pills Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. Europe Sleeping Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Sleeping Pills Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. China Sleeping Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Sleeping Pills Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. APAC Sleeping Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Sleeping Pills Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. Middle East, Africa and Latin America Sleeping Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Sleeping Pills Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Sleeping Pills Revenue in 2024
Figure 32. Sleeping Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 35. Global Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 37. North America Sleeping Pills Revenue Market Share by Company in 2024
Figure 38. North America Sleeping Pills Sales Quantity Market Share by Company in 2024
Figure 39. North America Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 41. North America Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 43. North America Sleeping Pills Revenue Share by Country (2018-2034)
Figure 44. North America Sleeping Pills Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Sleeping Pills Sales Quantity Market Share by Company in 2024
Figure 48. Europe Sleeping Pills Revenue Market Share by Company in 2024
Figure 49. Europe Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 51. Europe Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 53. Europe Sleeping Pills Revenue Share by Country (2018-2034)
Figure 54. Europe Sleeping Pills Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 56. France Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 60. China Sleeping Pills Sales Quantity Market Share by Company in 2024
Figure 61. China Sleeping Pills Revenue Market Share by Company in 2024
Figure 62. China Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 64. China Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 66. APAC Sleeping Pills Sales Quantity Market Share by Company in 2024
Figure 67. APAC Sleeping Pills Revenue Market Share by Company in 2024
Figure 68. APAC Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 70. APAC Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 72. APAC Sleeping Pills Revenue Share by Region (2018-2034)
Figure 73. APAC Sleeping Pills Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 78. India Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Sleeping Pills Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Sleeping Pills Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Sleeping Pills Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Sleeping Pills Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Sleeping Pills Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Sleeping Pills Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Sleeping Pills Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Sleeping Pills Revenue Share by Country (2018-2034)
Figure 87. Brazil Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Sleeping Pills Revenue (2018-2034) & (US$ Million)
Figure 92. Sleeping Pills Value Chain
Figure 93. Sleeping Pills Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed